Avedro Announces FDA Priority Review Status! – Corneal Cross-linking! This is huge news for the keratoconic community. The priority review status for the New Drug Application (NDA) places the application action date at March 15th, 2014.
Read MoreAvedro Announces FDA Priority Review Status! – Corneal Cross-linking! This is huge news for the keratoconic community. The priority review status for the New Drug Application (NDA) places the application action date at March 15th, 2014.
Read More